Cellceutix plans to present both topline findings from the complete Brilacidin-UP/UPS trial as well as interim data from its ongoing Phase 2 trial of Brilacidin for Oral Mucositis at the Drug Discovery and Therapy World Congress 2017 to be held July 10 – 13, 2017 in Boston.

More details to come.